Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Frei

Showing results (401-410 of 428) with videos related to

Pageof 43
Sort By:
International Journal of Cancer|January 21, 1991
Characteristics of five human tumor cell lines and sublines resistant to cis-diamminedichloroplatinum(II)B A Teicher, S A Holden, T S Herman, et al.
Cancer|December 1, 1972
Chemotherapy of sarcomas with a combination of adriamycin and dimethyl triazeno imidazole carboxamideJ A Gottlieb, L H Baker, J M Quagliana, et al.
Cancer Investigation|July 19, 2001
Cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) for advanced-stage Hodgkin's disease: CALGB 8856E P Lester, G R Petroni, M Barcos, et al.
Lancet (London, England)|June 28, 1980
Comparison of three methods of central-nervous-system prophylaxis in childhood acute lymphoblastic leukaemiaD M Green, A I Freeman, H N Sather, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1990
A phase I-II study of cyclophosphamide, thiotepa, and carboplatin with autologous bone marrow transplantation in solid tumor patientsJ P Eder, A Elias, T C Shea, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1987
Weekly high-dose methotrexate and doxorubicin for osteosarcoma: the Dana-Farber Cancer Institute/the Children's Hospital--study IIIA M Goorin, A Perez-Atayde, M Gebhardt, et al.
Annals of Internal Medicine|May 1, 1980
Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer InstituteV T DeVita, R M Simon, S M Hubbard, et al.
Bone Marrow Transplantation|March 30, 2001
A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancerA D Elias, P Richardson, D Avigan, et al.
Archives of Dermatology|June 1, 1988
Malignant melanoma. Treatment with high-dose combination alkylating agent chemotherapy and autologous bone marrow supportT C Shea, K H Antman, J P Eder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1996
Double dose-intensive chemotherapy with autologous stem-cell support for metastatic breast cancer: no improvement in progression-free survival by the sequence of high-dose melphalan followed by cyclophosphamide, thiotepa, and carboplatinL J Ayash, A Elias, G Schwartz, et al.
Pageof 43

Showing results (401-410 of 428) with videos related to

Sort By:
Pageof 43
International Journal of Cancer|January 21, 1991
Characteristics of five human tumor cell lines and sublines resistant to cis-diamminedichloroplatinum(II)B A Teicher, S A Holden, T S Herman, et al.
Cancer|December 1, 1972
Chemotherapy of sarcomas with a combination of adriamycin and dimethyl triazeno imidazole carboxamideJ A Gottlieb, L H Baker, J M Quagliana, et al.
Cancer Investigation|July 19, 2001
Cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) for advanced-stage Hodgkin's disease: CALGB 8856E P Lester, G R Petroni, M Barcos, et al.
Lancet (London, England)|June 28, 1980
Comparison of three methods of central-nervous-system prophylaxis in childhood acute lymphoblastic leukaemiaD M Green, A I Freeman, H N Sather, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1990
A phase I-II study of cyclophosphamide, thiotepa, and carboplatin with autologous bone marrow transplantation in solid tumor patientsJ P Eder, A Elias, T C Shea, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1987
Weekly high-dose methotrexate and doxorubicin for osteosarcoma: the Dana-Farber Cancer Institute/the Children's Hospital--study IIIA M Goorin, A Perez-Atayde, M Gebhardt, et al.
Annals of Internal Medicine|May 1, 1980
Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer InstituteV T DeVita, R M Simon, S M Hubbard, et al.
Bone Marrow Transplantation|March 30, 2001
A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancerA D Elias, P Richardson, D Avigan, et al.
Archives of Dermatology|June 1, 1988
Malignant melanoma. Treatment with high-dose combination alkylating agent chemotherapy and autologous bone marrow supportT C Shea, K H Antman, J P Eder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1996
Double dose-intensive chemotherapy with autologous stem-cell support for metastatic breast cancer: no improvement in progression-free survival by the sequence of high-dose melphalan followed by cyclophosphamide, thiotepa, and carboplatinL J Ayash, A Elias, G Schwartz, et al.
Pageof 43